Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Basroparib by ST Pharm for Kidney Cancer (Renal Cell Cancer): Likelihood of Approval
Basroparib is under clinical development by ST Pharm and currently in Phase I for Kidney Cancer (Renal Cell Cancer). According...
Basroparib by ST Pharm for Hepatocellular Carcinoma: Likelihood of Approval
Basroparib is under clinical development by ST Pharm and currently in Phase I for Hepatocellular Carcinoma. According to GlobalData, Phase...
Basroparib by ST Pharm for Gastric Cancer: Likelihood of Approval
Basroparib is under clinical development by ST Pharm and currently in Phase I for Gastric Cancer. According to GlobalData, Phase...
Basroparib by ST Pharm for Colorectal Cancer: Likelihood of Approval
Basroparib is under clinical development by ST Pharm and currently in Phase I for Colorectal Cancer. According to GlobalData, Phase...